A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer (ENTHUSE M1C)

Clinical Trial ID NCT00617669

PubWeight™ 22.04^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00617669

Top papers